Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study

NCT07748611 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT07748611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07748611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 3, 2027
Completion date
February 3, 2031
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline resectable pancreatic ductal adenocarcinoma, resectable pancreatic ductal adenocarcinoma